ATE144421T1 - Injizierbares arzneimittel und satz, die omoprazol oder verwandte verbindungenenthalten - Google Patents

Injizierbares arzneimittel und satz, die omoprazol oder verwandte verbindungenenthalten

Info

Publication number: ATE144421T1
Authority: AT; Austria
Prior art keywords: pct; omoprazole; related compounds; package containing; injectable drug
Prior art date: 1992-07-28

Application number

AT93916182T

Other languages

English (en)

Inventor

Shigeo Nakanishi

Tetsuo Tominaga

Iwao Yamanaka

Takashi Higo

Toshiyuki Shibata

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-28

Filing date

1993-07-15

Publication date

1996-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16437061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE144421(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-07-15 Application filed by Astra Ab filed Critical Astra Ab

1996-11-15 Application granted granted Critical

1996-11-15 Publication of ATE144421T1 publication Critical patent/ATE144421T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Plural Heterocyclic Compounds (AREA)
Dental Preparations (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

AT93916182T 1992-07-28 1993-07-15 Injizierbares arzneimittel und satz, die omoprazol oder verwandte verbindungenenthalten ATE144421T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP20120392		1992-07-28

Publications (1)

Publication Number	Publication Date
ATE144421T1 true ATE144421T1 (de)	1996-11-15

Family

ID=16437061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93916182T ATE144421T1 (de)	1992-07-28	1993-07-15	Injizierbares arzneimittel und satz, die omoprazol oder verwandte verbindungenenthalten

Country Status (20)

Country	Link
US (1)	US5589491A (de)
EP (1)	EP0652751B1 (de)
KR (1)	KR100258423B1 (de)
AT (1)	ATE144421T1 (de)
AU (1)	AU674015B2 (de)
CA (1)	CA2140347C (de)
CZ (1)	CZ284249B6 (de)
DE (1)	DE69305642T2 (de)
DK (1)	DK0652751T3 (de)
ES (1)	ES2093445T3 (de)
FI (1)	FI113338B (de)
GR (1)	GR3021937T3 (de)
HK (1)	HK52397A (de)
HU (1)	HU226778B1 (de)
NO (1)	NO304098B1 (de)
NZ (1)	NZ254237A (de)
RU (1)	RU2126252C1 (de)
SG (1)	SG52479A1 (de)
SK (1)	SK279554B6 (de)
WO (1)	WO1994002141A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4324014C2 (de) *	1993-07-17	1995-06-08	Byk Gulden Lomberg Chem Fab	Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
US6699885B2 (en)	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en)	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6096340A (en) *	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6174548B1 (en)	1998-08-28	2001-01-16	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6733778B1 (en)	1999-08-27	2004-05-11	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6262085B1 (en)	1999-08-26	2001-07-17	Robert R. Whittle	Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) *	1999-08-26	2001-11-13	Robert R. Whittle	Pharmaceutical formulations
US6268385B1 (en)	1999-08-26	2001-07-31	Robert R. Whittle	Dry blend pharmaceutical formulations
US6780880B1 (en)	1999-08-26	2004-08-24	Robert R. Whittle	FT-Raman spectroscopic measurement
US6312712B1 (en)	1999-08-26	2001-11-06	Robert R. Whittle	Method of improving bioavailability
US6262086B1 (en)	1999-08-26	2001-07-17	Robert R. Whittle	Pharmaceutical unit dosage form
US6326384B1 (en)	1999-08-26	2001-12-04	Robert R. Whittle	Dry blend pharmaceutical unit dosage form
US6312723B1 (en)	1999-08-26	2001-11-06	Robert R. Whittle	Pharmaceutical unit dosage form
US6369087B1 (en)	1999-08-26	2002-04-09	Robert R. Whittle	Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
SE9903831D0 (sv) *	1999-10-22	1999-10-22	Astra Ab	Formulation of substituted benzimidazoles
US7396841B2 (en)	2000-08-18	2008-07-08	Takeda Pharmaceutical Company Limited	Injections
AU2001296908A1 (en) *	2000-09-29	2002-04-08	Geneva Pharmaceuticals, Inc.	Proton pump inhibitor formulation
MY137726A (en)	2000-11-22	2009-03-31	Nycomed Gmbh	Freeze-dried pantoprazole preparation and pantoprazole injection
US20020192299A1 (en) *	2000-12-28	2002-12-19	Rajneesh Taneja	Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
KR100467100B1 (ko) *	2002-03-20	2005-01-24	일양약품주식회사	2-[(4-메톡시-3-메틸)-2-피리디닐]메틸설피닐-5-(1Ｈ-피롤-1-릴)-1Ｈ-벤즈이미다졸 또는 이의 Ｎа염을 함유하는주사제의 제조방법
US20030228363A1 (en) *	2002-06-07	2003-12-11	Patel Mahendra R.	Stabilized pharmaceutical compositons containing benzimidazole compounds
US20040082618A1 (en) *	2002-07-03	2004-04-29	Rajneesh Taneja	Liquid dosage forms of acid labile drugs
US20040006109A1 (en) *	2002-07-03	2004-01-08	Rajneesh Taneja	Liquid dosage forms of non-enterically coated acid-labile drugs
US20040081671A1 (en) *	2002-07-03	2004-04-29	Rajneesh Taneja	Liquid dosage forms of non-enterically coated acid-labile drugs
US20070243251A1 (en) *	2002-12-20	2007-10-18	Rajneesh Taneja	Dosage Forms Containing A PPI, NSAID, and Buffer
US20040121004A1 (en) *	2002-12-20	2004-06-24	Rajneesh Taneja	Dosage forms containing a PPI, NSAID, and buffer
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045258A1 (es) *	2003-08-21	2005-10-19	Altana Pharma Ag	Un producto farmaceutico para inyeccion
EP1713476B1 (de)	2003-11-05	2010-05-05	Lyka Labs Limited	Verfahren zur herstellung von benzimidazolen
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en)	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070026071A1 (en) *	2005-07-28	2007-02-01	Qpharma, Llc	Magnesium salt proton pump inhibitor dosage forms
WO2007091276A2 (en) *	2006-02-10	2007-08-16	Rajasthan Antibiotic Limited	Novel crystal form of omeprazol sodium
CN104288175A (zh) *	2014-09-17	2015-01-21	大生祥(武汉）中医投资管理有限公司	一种新的苯并咪唑类异构体制剂及其制备方法
PT3386507T (pt) *	2015-12-08	2023-09-11	Luoda Pharma Ltd	Métodos e composições para tratar úlceras gástricas
CN105919953A (zh) *	2016-06-27	2016-09-07	峨眉山通惠制药有限公司	一种注射用奥美拉唑钠组合物及其制作工艺
GB2585628A (en) *	2019-05-08	2021-01-20	Alkaloid Ad	Pharmaceutical formulation
CN112807282A (zh) *	2021-01-13	2021-05-18	海南葫芦娃药业集团股份有限公司	一种奥美拉唑钠冻干粉针剂及其制备方法
WO2024075017A1 (en)	2022-10-04	2024-04-11	Zabirnyk Arsenii	Inhibition of aortic valve calcification

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE416649B (sv) *	1974-05-16	1981-01-26	Haessle Ab	Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
US4359465A (en) *	1980-07-28	1982-11-16	The Upjohn Company	Methods for treating gastrointestinal inflammation
US4472409A (en) *	1981-11-05	1984-09-18	Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung	2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
SE8300736D0 (sv) *	1983-02-11	1983-02-11	Haessle Ab	Novel pharmacologically active compounds
SE8301182D0 (sv) *	1983-03-04	1983-03-04	Haessle Ab	Novel compounds
JPS6150978A (ja) *	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
DK399389A (da) *	1988-08-18	1990-02-19	Takeda Chemical Industries Ltd	Injicerbare oploesninger
DE69014141T2 (de) *	1989-02-10	1995-05-24	Takeda Chemical Industries Ltd	Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel.
US5049674A (en) *	1989-12-20	1991-09-17	Aktiebolaget Hassle	Therapeutically active fluoro substituted benzimidazoles

1993
- 1993-07-15 DE DE69305642T patent/DE69305642T2/de not_active Expired - Fee Related
- 1993-07-15 KR KR1019950700327A patent/KR100258423B1/ko not_active Expired - Fee Related
- 1993-07-15 SG SG1996005084A patent/SG52479A1/en unknown
- 1993-07-15 HU HU9500245A patent/HU226778B1/hu not_active IP Right Cessation
- 1993-07-15 NZ NZ254237A patent/NZ254237A/en not_active IP Right Cessation
- 1993-07-15 SK SK100-95A patent/SK279554B6/sk not_active IP Right Cessation
- 1993-07-15 ES ES93916182T patent/ES2093445T3/es not_active Expired - Lifetime
- 1993-07-15 CZ CZ95217A patent/CZ284249B6/cs not_active IP Right Cessation
- 1993-07-15 CA CA002140347A patent/CA2140347C/en not_active Expired - Lifetime
- 1993-07-15 EP EP93916182A patent/EP0652751B1/de not_active Expired - Lifetime
- 1993-07-15 AT AT93916182T patent/ATE144421T1/de not_active IP Right Cessation
- 1993-07-15 WO PCT/JP1993/000998 patent/WO1994002141A1/en active IP Right Grant
- 1993-07-15 US US08/373,245 patent/US5589491A/en not_active Expired - Lifetime
- 1993-07-15 RU RU95104936A patent/RU2126252C1/ru not_active IP Right Cessation
- 1993-07-15 AU AU45838/93A patent/AU674015B2/en not_active Ceased
- 1993-07-15 DK DK93916182.4T patent/DK0652751T3/da active
1995
- 1995-01-17 NO NO950178A patent/NO304098B1/no not_active IP Right Cessation
- 1995-01-27 FI FI950379A patent/FI113338B/fi active
1996
- 1996-12-06 GR GR960403351T patent/GR3021937T3/el unknown
1997
- 1997-04-24 HK HK52397A patent/HK52397A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69305642T2 (de)	1997-02-27
NO304098B1 (no)	1998-10-26
FI113338B (fi)	2004-04-15
FI950379A0 (fi)	1995-01-27
GR3021937T3 (en)	1997-03-31
NZ254237A (en)	1995-12-21
CZ21795A3 (en)	1995-10-18
HU226778B1 (en)	2009-10-28
US5589491A (en)	1996-12-31
CZ284249B6 (cs)	1998-10-14
EP0652751A1 (de)	1995-05-17
SG52479A1 (en)	1998-09-28
SK279554B6 (sk)	1998-12-02
CA2140347C (en)	2001-03-27
CA2140347A1 (en)	1994-02-03
KR950702419A (ko)	1995-07-29
SK10095A3 (en)	1995-07-11
DE69305642D1 (de)	1996-11-28
KR100258423B1 (ko)	2000-07-01
EP0652751B1 (de)	1996-10-23
AU4583893A (en)	1994-02-14
FI950379L (fi)	1995-01-27
HUT71900A (en)	1996-02-28
RU2126252C1 (ru)	1999-02-20
AU674015B2 (en)	1996-12-05
DK0652751T3 (da)	1996-11-18
HU9500245D0 (en)	1995-03-28
ES2093445T3 (es)	1996-12-16
WO1994002141A1 (en)	1994-02-03
HK52397A (en)	1997-05-02
NO950178L (no)	1995-01-17
NO950178D0 (no)	1995-01-17

Publication	Publication Date	Title
ATE144421T1 (de)	1996-11-15	Injizierbares arzneimittel und satz, die omoprazol oder verwandte verbindungenenthalten
ATE163418T1 (de)	1998-03-15	Risperidon pamoate
FI920439A0 (fi)	1992-01-31	Termoformbara foereningar, deras framstaellningsfoerfarande och deras anvaendning vid framstaellning av termoformade artiklar.
MY105136A (en)	1994-08-30	Optically active pyridonecarboxylic acid derivatives.
ATE248824T1 (de)	2003-09-15	Substituierte phenylderivate, ihre herstellung und verwendung
MY129973A (en)	2007-05-31	Sulphonylbenzyl-substituted pyridones.
YU46998B (sh)	1994-11-15	Postupak za dobijanje derivata cefema i medjuproizvoda za iste
ES2086538T3 (es)	1996-07-01	Medicamento para el tratamiento de la hiperlipemia y/o aterosclerosis.
NO980531L (no)	1998-04-06	Medikament for å hemme avhengighet og toleranse utviklet ved narkotisk smertestillende middel
KR900701262A (ko)	1990-12-01	췌장염 등에 대한 치료제
DE59404557D1 (de)	1997-12-18	Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
NO941084D0 (no)	1994-03-24	Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
ATE88634T1 (de)	1993-05-15	Arzneimittel zur behandlung von herzinsuffizienz.
NO932133D0 (no)	1993-06-10	Imidazolyl-substituerte cykloheksanderivater
DK0438813T3 (da)	1998-07-27	Nyt antibiotikum, deoxymulundocandin, en fremgangsmåde til dets fremstilling samt dets anvendelse som lægemiddel
AR247095A1 (es)	1994-11-30	Composicion limpida, acuosa, estable en estante, para el tenido del cabello humano.
NO162462C (no)	1990-01-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-(2-alkoksyfenyl)-tiazolidindion-derivater.
ATE169819T1 (de)	1998-09-15	(-)-metrifonat enthaltendes arzneimittel
MX9302176A (es)	1993-10-01	Derivados de benzofenona
EP0651945A4 (de)	1995-10-04	Mittel zum schutz vor termiten.
ATE158503T1 (de)	1997-10-15	Aids-virus-infektion hemmende zusammensetzung
KR900701781A (ko)	1990-12-04	신규 1,3,4-티아디아졸 유도체 및 그 유도체를 유효성분으로 하는 항궤양제
NO306673B1 (no)	1999-12-06	Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse
ITRM940018V0 (it)	1994-02-01	Chiusura applicabile a tutti i tipi di moschettoni.
SU1531433A1 (ru)	2006-12-20	4-(n-Фторфенил)-5-фенил-2-(α-гидрокси-α -карбометокситрифторэтил)-тиофен, проявляющий антимикробную и противовоспалительную активность

Legal Events

Date	Code	Title	Description
1997-05-15	UEP	Publication of translation of european patent specification
2010-04-15	REN	Ceased due to non-payment of the annual fee